Prostaglandin Reductase 1 as a Potential Therapeutic Target for Cancer Therapy

Altered tumor metabolism is a hallmark of cancer and targeting tumor metabolism has been considered as an attractive strategy for cancer therapy. Prostaglandin Reductase 1 (PTGR1) is a rate-limiting enzyme involved in the arachidonic acid metabolism pathway and mainly responsible for the deactivatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xing, Yin, Guobing, Zhang, Wei, Song, Kunling, Zhang, Longbin, Guo, Zufeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377670/
https://www.ncbi.nlm.nih.gov/pubmed/34421612
http://dx.doi.org/10.3389/fphar.2021.717730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377670/
https://www.ncbi.nlm.nih.gov/pubmed/34421612
http://dx.doi.org/10.3389/fphar.2021.717730

Ejemplares similares